Patent Applications published on Mar 20, 2025 - page 4

#901
US20250090489A1
Human necessities

CATIONIC POLYMERIC NANOCARRIERS INHIBIT CHEMOTHERAPY-INDUCED CANCER METASTASIS AND COGNITIVE IMPAIRMENT

#902
US20250090490A1
Human necessities

Compositions of Azadirachta Indica and Methods of Treating Cancer

#903
US20250090491A1
Human necessities

ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS

#904
US20250090492A1
Human necessities

Liquid Tasimelteon Formulations and Methods of Use Thereof

#905
US20250090493A1
Human necessities

THERAPEUTIC COMPOSITION DELIVERY DEVICE

#906
US20250090494A1
Human necessities

CANNABIDIOL COMPOSITIONS HAVING MODIFIED CANNABINOID PROFILES

#907
US20250090495A1
Human necessities

CDC7 Inhibitor Combinational Therapy

#908
US20250090496A1
Human necessities

LASOFOXIFENE TREATMENT OF BREAST CANCER

#909
US20250090497A1
Human necessities

METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR

#910
US20250090498A1
Human necessities

TREATMENT OF PRIMARY CTLA-4 CHECKPOINT RELATED IMMUNODEFICIENCIES

#911
US20250090499A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING BONE HEALTH USING SELF-EMULSIFYING FORMULATIONS OF DIINDOLYLMETHANE

#912
US20250090500A1
Human necessities

COMPOUNDS USEFUL AS KINASE INHIBITORS

#913
US20250090501A1
Human necessities

METHODS OF TREATING GUT MOTILITY DISORDERS

#914
US20250090502A1
Human necessities

METHODS OF TREATING, AMELIORATING, AND/OR PREVENTING BACTERIAL INFECTION, OR METHODS OF REDUCING ADVERSE EFFECTS CAUSED BY BACTERIA

#915 ✅ Patent 12,280,040 granted on 2025-04-22
US20250090503A1
Human necessities

Compositions and methods of a dihydroisoxazole compound that reduces ectoparasite infestations on fish

#916
US20250090504A1
Human necessities

SMALL MOLECULE PEPTIDOMIMETIC FOR THE TREATMENT OF TAUOPATHIES

#917
US20250090505A1
Human necessities

Methods for Preventing Ectopic Brain Mineralization in Alzheimer's Disease and Dementias

#918
US20250090506A1
Human necessities

COMBINATION THERAPY FOR THE TREATMENT OF MASTOCYTOSIS

#919
US20250090507A1
Human necessities

Methods of Treating Cancer With a B-RAF Inhibitor

#920
US20250090508A1
Human necessities

METHODS OF REDUCING ITCH USING TOPICAL ROFLUMILAST COMPOSITIONS

#921
US20250090509A1
Human necessities

METHODS OF REDUCING ITCH USING TOPICAL ROFLUMILAST COMPOSITIONS

#922
US20250090510A1
Human necessities

eIF4G1-eIF1 INHIBITORS AND USE THEREOF

#923
US20250090511A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

#924
US20250090512A1
Human necessities

Dosage Regimen

#925
US20250090513A1
Human necessities

DOSING REGIMEN OF HIV CAPSID INHIBITOR

#926
US20250090514A1
Human necessities

METHOD OF TREATING CANCER

#927
US20250090515A1
Human necessities

1-Deoxynojirimycin To Mitigate Hepatic Ischemia- Reperfusion

#928
US20250090516A1
Human necessities

DRUG FOR TREATING AFTEREFFECTS OF NOVEL CORONAVIRUS INFECTION

#929
US20250090517A1
Human necessities

Methods of Treating Cancer

#930
US20250090518A1
Human necessities

METHOD OF TREATMENT WITH MILSAPERIDONE

#931
US20250090519A1
Human necessities

TREATMENT OF CARDIOPULMONARY DISORDERS

#932
US20250090520A1
Human necessities

DERIVATIVES OF TURBINMICIN AS ANTIFUNGAL AGENTS

#933
US20250090521A1
Human necessities

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

#934
US20250090522A1
Human necessities

LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF CORONAVIRUS DISEASE AND SYMPTOMS THEREOF

#935
US20250090523A1
Human necessities

PHARMACEUTICAL COMPOSITION OR DRUG KIT FOR ALLEVIATING OR TREATING FIBROTIC DISEASES, AND USE THEREOF

#936
US20250090524A1
Human necessities

BTK INHIBITORS

#937
US20250090525A1
Human necessities

Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate

#938
US20250090526A1
Human necessities

METHODS OF TREATING DISORDERS ASSOCIATED WITH CASTOR

#939
US20250090527A1
Human necessities

WOUND TREATMENTS AND COMPOUNDS

#940
US20250090528A1
Human necessities

USE OF COMPLEMENT FACTOR D INHIBITOR FOR TREATMENT OF LUPUS NEPHRITIS AND IMMUNOGLOBULIN A NEPHROPATHY

#941
US20250090529A1
Human necessities

USE OF SHP2 INHIBITORS FOR THE TREATMENT OF INSULIN RESISTANCE

#942
US20250090530A1
Human necessities

COMBINATIONS FOR THE TREATMENT OF CANCER

#943
US20250090531A1
Human necessities

Ribociclib Tablet

#944
US20250090532A1
Human necessities

SHP2 INHIBITOR COMPOSITIONS AND METHODS FOR TREATING CANCER

#945
US20250090533A1
Human necessities

COMBINATION THERAPY COMPRISING A MAT2A INHIBITOR AND A TAXANE

#946
US20250090534A1
Human necessities

Phosphodiesterase-5 Inhibitor Combinations, Methods of Making, and Methods of Use Thereof

#947
US20250090535A1
Human necessities

STABLE FORMULATIONS OF SHR0302

#948
US20250090536A1
Human necessities

USES

#949
US20250090537A1
Human necessities

ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

#950
US20250090538A1
Human necessities

TLR7/8-ANTAGONIST FOR TREATING SJÖGREN'S SYNDROME OR MIXED CONNECTIVE TISSUE DISEASE

#951
US20250090539A1
Human necessities

COMBINATION TREATMENT OF CANCERS

#952
US20250090540A1
Human necessities

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

#953
US20250090541A1
Human necessities

Methods for Treating Neurodegenerative Disorders

#954
US20250090542A1
Human necessities

COMBINATION OF A CELL THERAPY AND A GAMMA SECRETASE INHIBITOR

#955
US20250090543A1
Human necessities

CXCR7 INHIBITORS FOR THE TREATMENT OF CANCER

#956
US20250090544A1
Human necessities

ANTIPSYCHOTIC AND USE THEREOF

#957
US20250090545A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES

#958
US20250090546A1
Human necessities

CHLOROPHYLL COMPOSITION

#959
US20250090547A1
Human necessities

EPA-EE LIPID NANOCOMPOSITE, FORMULATION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

#960
US20250090548A1
Human necessities

J-SERIES PROSTAGLANDIN-ETHANOLAMIDES AS NOVEL THERAPEUTICS FOR SKIN AND/OR ORAL DISORDERS

#961
US20250090549A1
Human necessities

COMPOSITIONS AND METHODS FOR MUSCLE REGENERATION USING PROSTAGLANDIN E2

#962
US20250090550A1
Human necessities

INJECTABLE COMPOSITION COMPRISING CYTOLYTIC COMPOUND IN GEL, GEL-FORMING SOLUTION OR GEL-FORMING SUSPENSION FOR REDUCTION OF FAT

#963
US20250090551A1
Human necessities

BUDESONIDE 21-PHOSPHATE SODIUM SALT FOR USE AS ANTI-INFLAMMATORY OR ANTIASTHMATIC AGENT

#964
US20250090552A1
Human necessities

MESALAMINE PHARMACEUTICAL FORMULATIONS AND METHODS OF USE THEREOF

#965
US20250090553A1
Human necessities

SUSTAINED RELEASE COMPOSITION COMPRISING A HYDROXYALKYL METHYLCELLULOSE

#966
US20250090554A1
Human necessities

A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION

#967
US20250090555A1
Human necessities

METHOD FOR PRODUCING A CBD COMPRISING LIQUID OR SOLID AND USE THEREOF

#968
US20250090556A1
Human necessities

Polycannabinoid Compositions and Uses Thereof

#969
US20250090557A1
Human necessities

Compositions and Methods for Inhibiting and Treating Coronavirus Infections

#970
US20250090558A1
Human necessities

APPLICATION OF MILTEFOSINE IN PROMOTING BONE FORMATION AND PREVENTING-TREATING OSTEOPOROSIS

#971
US20250090559A1
Human necessities

PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME

#972
US20250090560A1
Human necessities

T CELL RECEPTORS FOR IMMUNOTHERAPY

#973
US20250090561A1
Human necessities

LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS

#974
US20250090562A1
Human necessities

METHODS, COMPOSITIONS AND USES RELATED TO THE TREATMENT AND PREVENTION OF LEIGH’S SYNDROME

#975
US20250090563A1
Human necessities

COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF INFLAMMATORY BOWEL DISEASE COMPRISING GALACTO-OLIGOSACCHARIDE

#976
US20250090564A1
Human necessities

BIOACTIVES AND THEIR USES

#977
US20250090565A1
Human necessities

Compositions and Methods for Treating Bleeding and Bleeding Disorders

#978
US20250090566A1
Human necessities

BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF

#979
US20250090567A1
Human necessities

5-FU AND RNAOG COMBINED IMMUNOCHEMOTHERAPY FOR PANCREATIC CANCER TREATMENT

#980
US20250090568A1
Human necessities

METHOD OF TREATING LONG-COVID INDUCED NEUROLOGIC DISEASES

#981
US20250090569A1
Human necessities

EXON SKIPPING OLIGOMERS AND OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

#982
US20250090570A1
Human necessities

Method for Prophylaxis and Attenuation of COVID19 and other Inflammatory Microbial Acute Respiratory Disease Syndromes through Modulation of Innate and Adaptive Immunity with Poly ICLC

#983
US20250090571A1
Human necessities

CARD9 ATTENUATES AB PATHOLOGY AND MODIFIES MICROGLIAL RESPONSES IN AN ALZHEIMER’S DISEASE

#984
US20250090572A1
Human necessities

COMPOSITIONS INCORPORATING SULFATED POLYSACCHARIDES FOR INHIBITING SARS-COV-2

#985
US20250090573A1
Human necessities

COMPOSITIONS FOR DELIVERING NITRIC OXIDE AND FLUORIDE AND METHODS FOR MAKING AND USING THE SAME

#986
US20250090574A1
Human necessities

BIOMATERIAL COMPRISING POLY(ITACONATE-CO-DODECANEDIOL)

#987
US20250090575A1
Human necessities

SYSTEM AND METHOD OF USE FOR HALOTHERAPY SESSIONS

#988
US20250090576A1
Human necessities

METHODS FOR TREATING NONTUBERCULOUS MYCOBACTERIA DISEASES

#989
US20250090577A1
Human necessities

CLAY MINERAL BIOMATERIAL, AND PREPARATION METHOD AND USE THEREOF

#990
US20250090578A1
Human necessities

METHOD OF PRODUCING A POPULATION OF IMMUNE CELLS FROM PLURIPOTENT STEM CELLS

#991
US20250090579A1
Human necessities

DNVSIG3 AND DNVSIG8 RECEPTORS AND METHODS OF USING THE SAME

#992
US20250090580A1
Human necessities

METHODS AND COMPOSITIONS FOR USING ACTIVATED LYMPHOCYTES IN THE TREATMENT OF DISEASE

#993
US20250090581A1
Human necessities

MULTISTEP PROCESS FOR CULTURING TUMOR-INFILTRATING LYMPHOCYTES FOR THERAPEUTIC USE

#994
US20250090582A1
Human necessities

GENETICALLY ENGINEERED CELLS HAVING ANTI-CD133 / ANTI-EGFR CHIMERIC ANTIGEN RECEPTORS, AND USES THEREOF

#995
US20250090583A1
Human necessities

UNIVERSAL TCR VARIANTS FOR ALLOGENEIC IMMUNOTHERAPY

#996
US20250090584A1
Human necessities

TREATMENT OF AUTOIMMUNE DISEASES WITH ENGINEERED IMMUNE CELLS

#997
US20250090585A1
Human necessities

MODIFIED REGULATORY T CELLS AND METHODS OF USING THE SAME

#998
US20250090586A1
Human necessities

METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF

#999
US20250090587A1
Human necessities

PLATELET-DERIVED MITOCHONDRIA-CONTAINING EXTRACELLULAR VESICLES FOR USE IN THE TREATMENT OF OCULAR DISORDERS

#1000
US20250090588A1
Human necessities

METHODS OF TREATING OR PREVENTING PREMATURE OVARIAN INSUFFICIENCY, POLYCYSTIC OVARY SYNDROME, OR INFERTILITY USING EXOSOMES OR MESENCHYMAL STEM CELLS

#1001
US20250090589A1
Human necessities

METHOD OF TREATING PROGRESSIVE HEART FAILURE IN SUBJECTS AT HIGH RISK OF POOR OUTCOMES

#1002
US20250090590A1
Human necessities

MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO

#1003
US20250090591A1
Human necessities

MESENCHYMAL STEM CELL WOUND REPAIR DOMINANT FUNCTIONAL CLUSTER, IDENTIFICATION THEREOF, AND APPLICATION

#1004
US20250090592A1
Human necessities

Treatment of Mitochondrial Disease with Autologous Expanded Mesenchymal Stem Cell Therapy

#1005
US20250090593A1
Human necessities

METHOD FOR PRODUCING HYDROGEL MICROBEADS CAPABLE OF MAGNETIC ACTUATION FOR DELIVERY OF THERAPEUTIC SUBSTANCE, HYDROGEL MICROBEADS PRODUCED THEREBY, AND PHARMACEUTICAL COMPOSITION FOR TREATING MUSCULOSKELETAL DISORDERS COMPRISING SAME

#1006
US20250090594A1
Human necessities

THERAPEUTIC USE OF FIBROBLASTS TO STIMULATE THE IMMUNE SYSTEM

#1007
US20250090595A1
Human necessities

THERAPEUTIC USE OF CANCER-ASSOCIATED FIBROBLAST-ENCAPSULATED PANCREATIC BETA CELLS FOR TREATING DIABETES

#1008
US20250090596A1
Human necessities

MODULATING INFLAMMATION ASSOCIATED WITH FOREIGN BODY RESPONSE

#1009
US20250090597A1
Human necessities

AIRWAY BASAL CELL ENGRAFTMENT METHODS

#1010
US20250090598A1
Human necessities

SYSTEMS AND METHODS FOR THROMBOSIS PREVENTION

#1011
US20250090599A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY SKIN DISEASE WITH RECOMBINANT MICROORGANISMS

#1012
US20250090600A1
Human necessities

MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITION AND METHODS OF MANUFACTURE

#1013
US20250090601A1
Human necessities

COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT

#1014
US20250090602A1
Human necessities

AMMONIA OXIDIZING MICROORGANISMS FOR THE REGULATION OF BLOOD PRESSURE

#1015
US20250090603A1
Human necessities

COMPOSITIONS CONTAINING BACILLAENE PRODUCING BACTERIA OR PREPARATIONS THEREOF

#1016
US20250090604A1
Human necessities

STRAIN OF PEDIOCOCCUS ACIDILACTICI WITH FUNCTION OF TREATING ULCERATIVE COLITIS AND APPLICATION THEREOF

#1017
US20250090605A1
Human necessities

NOVEL LACTOBACILLUS PARACASEI ATG-E1 STRAIN OR COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING RESPIRATORY DISEASE

#1018
US20250090606A1
Human necessities

COMPOSITIONS FOR TREATMENT OF A FATTY LIVER OR FIBROTIC LIVER DISEASE

#1019
US20250090607A1
Human necessities

FASTING-MIMICKING DIET (FMD) BUT NOT WATER-ONLY FASTING PROMOTES REVERSAL OF INFLAMMATION AND IBD PATHOLOGY

#1020
US20250090608A1
Human necessities

BACTERIOPHAGE HAVING BACTERIOLYSIS ACTIVITY ON XANTHOMONAS SPP.

#1021
US20250090609A1
Human necessities

COMPOSITIONS AND METHODS FOR PROMOTING DEVELOPMENT OF INFANT

#1022
US20250090610A1
Human necessities

COMPOSITION, AND EXTRACT OF CHLAMYDOMONAS REINHARDTII

#1023
US20250090611A1
Human necessities

T CELL DIFFERENTIATION-REGULATING AGENT AND COMPOSITION

#1024
US20250090612A1
Human necessities

FEED ADDITIVE COMPOSITIONS AND METHODS OF USE

#1025
US20250090613A1
Human necessities

AN ANTI-CANCER HERBAL COMPOSITION

#1026
US20250090614A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING LUNG FUNCTION

#1027
US20250090615A1
Human necessities

MULTIVITAMIN FOR AUXILIARY REGULATION OF BLOOD PRESSURE AND PREPARATION METHOD AND APPLICATION THEREOF

#1028
US20250090616A1
Human necessities

COMPOSITION FOR IMPROVING SLEEP

#1029
US20250090617A1
Human necessities

FORMULATIONS FOR TREATING OBESITY AND DIABETES AND FOR PROVIDING OTHER HEALTH RELATED BENEFITS

#1030
US20250090618A1
Human necessities

COMBINATION FOR USE FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA, CARDIOVASCULAR DISEASE AND METABOLIC SYNDROME

#1031
US20250090619A1
Human necessities

SINGLE PROCESS FOR SEQUENTIAL EXTRACTION OF PRODUCTS FROM GREEN TEA LEAVES

#1032
US20250090620A1
Human necessities

PRODUCTION OF PROTECTIVE LOZENGE/CHEWABLE TABLET AGAINST SARS-COV-2 VIRUS

#1033
US20250090621A1
Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION

#1034
US20250090622A1
Human necessities

ANGIOTENSIN COMPOSITIONS AND METHODS RELATED THERETO

#1035 ✅ Patent 12,343,372 granted on 2025-07-01
US20250090623A1
Human necessities

DESMOPRESSIN ORAL COMPOSITIONS

#1036
US20250090624A1
Human necessities

MODULATORS OF COMPLEMENT ACTIVITY

#1037
US20250090625A1
Human necessities

CYCLOSPORINE FORMULATIONS FOR USE IN THE TREATMENT OF BRONCHIOLITIS OBLITERANS SYNDROME (BOS)

#1038
US20250090626A1
Human necessities

NEW PEPTIDE AND USES THEREOF

#1039
US20250090627A1
Human necessities

NUTRITIONAL POLYPEPTIDE HAVING BRANCHED-STRUCTURE WITH EFFICIENT BROAD-SPECTRUM ANTIBACTERIAL AND ANTIFUNGAL FUNCTIONS

#1040
US20250090628A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS

#1041
US20250090629A1
Human necessities

ALLEVIATING DRUG NEPHROTOXICITY

#1042
US20250090630A1
Human necessities

USE OF PBX1 IN PROMOTING HAIR GROWTH

#1043
US20250090631A1
Human necessities

Method to Treat Cancer with Engineered T-Cells

#1044
US20250090632A1
Human necessities

Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody

#1045
US20250090633A1
Human necessities

THERAPEUTIC COMPOSITIONS AND METHODS OF USE THEREOF

#1046
US20250090634A1
Human necessities

LYMPHANGIOGENESIS-PROMOTING AGENTS

#1047
US20250090635A1
Human necessities

TREATMENT OF INTERVERTEBRAL DISC DEGENERATION

#1048
US20250090636A1
Human necessities

H3.3 CTL PEPTIDES AND USES THEREOF

#1049
US20250090637A1
Human necessities

METHODS OF INHIBITING CEREBRAL INFLAMMATION

#1050
US20250090638A1
Human necessities

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN AGONIST RECEPTOR OR AN AMYLIN ANALOGUE AND A CO-POLYAMINO ACID

#1051
US20250090639A1
Human necessities

CONTROLLED-RELEASE CNP AGONISTS WITH LOW INITIAL NPR-B ACTIVITY

#1052
US20250090640A1
Human necessities

METHOD OF IMPROVING THE VIABILITY OF A DENTAL IMPLANT

#1053
US20250090641A1
Human necessities

EXPRESSION VECTOR FOR CHOLESTEROL 24-HYDROLASE IN THERAPY OF POLYGLUTAMINE REPEAT SPINOCEREBELLAR ATAXIAS

#1054
US20250090642A1
Human necessities

FOOD COMPOSITION FOR IMPROVING BEHAVIORAL AND MOTOR FUNCTION CONTAINING ALDEHYDE DEHYDROGENASE FOR REDUCING ALDEHYDES PRODUCED BY OXIDATION OF AMINE

#1055
US20250090643A1
Human necessities

FUNCTIONALIZED BIOCATALYTICAL COMPOSITIONS

#1056
US20250090644A1
Human necessities

E. COLI EXPRESSED RECOMBINANT HUMAN MICROPLASMIN, A PRODUCTION METHOD THEREOF, A PHARMACEUTICAL COMPOSITION AND A KIT COMPRISING THEREOF, A METHOD AND AN APPLICATION OF TREATING THROMBOEMBOLISM RELATED DISEASES BY USING THEREOF

#1057
US20250090645A1
Human necessities

Radiohalogenated Agents for in Situ Immune Modulated Cancer Vaccination

#1058
US20250090646A1
Human necessities

METHODS OF TREATING CANCER USING HETEROARYL-BIPHENYL AMIDE DERIVATIVES

#1059
US20250090647A1
Human necessities

OPTIMIZED MULTIDIMENSIONAL BIOLOGICAL ACTIVITY OF POLY-ICLC WITH CONTROLLED COMPONENT SIZE AND FORMULATION

#1060
US20250090648A1
Human necessities

NEXT GENERATION MRNA VACCINES

#1061
US20250090649A1
Human necessities

INFLUENZA VIRUS MUTANTS AND USES THEREFOR

#1062
US20250090650A1
Human necessities

MODIFIED INFLUENZA B HEMAGGLUTININ POLYPEPTIDES AND NUCLEIC ACIDS AND USES THEREOF

#1063
US20250090651A1
Human necessities

RESPIRATORY SYNCYTIAL VIRUS F PROTEINS AND NANOSTRUCTURES AND USES THEREOF

#1064
US20250090652A1
Human necessities

HENIPAVIRUS VACCINE

#1065
US20250090653A1
Human necessities

SARS COV-2 VACCINE, ASSOCIATED POLYNUCLEOTIDES, AND METHODS OF USE

#1066
US20250090654A1
Human necessities

CORONAVIRUS VACCINE COMPOSITIONS AND USES THEREOF

#1067
US20250090655A1
Human necessities

BOOSTING SARS-COV-2 IMMUNITY WITH A LENTIVIRAL-BASED NASAL VACCINE

#1068
US20250090656A1
Human necessities

NUCLEIC ACID VACCINE AGAINST THE SARS-COV-2 CORONAVIRUS

#1069
US20250090657A1
Human necessities

NUCLEIC ACID VACCINE AGAINST THE SARS-COV-2 CORONAVIRUS

#1070
US20250090658A1
Human necessities

POLYMER ADJUVANT

#1071
US20250090659A1
Human necessities

COMBINATION THERAPY WITH AN ANTI-CD19 ANTIBODY AND PARSACLISIB

#1072
US20250090660A1
Human necessities

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

#1073
US20250090661A1
Human necessities

EXPANSION OF HUMAN GROUP 2 INNATE LYMPHOID CELLS AND METHODS OF USE THEREOF

#1074
US20250090662A1
Human necessities

COMPOSITION AND METHOD OF USE RECOMBINANT FUSION PROTEIN TO GENERATE CAR-IMMUNE CELLS

#1075
US20250090663A1
Human necessities

BINDING DOMAINS AND METHODS OF USE THEREOF

#1076
US20250090664A1
Human necessities

PIEZOELECTRIC SHEAR-THINNING MATERIAL COMPOSITIONS AND METHODS FOR USE

#1077
US20250090665A1
Human necessities

SCINTILLATOR NANOCRYSTAL-CONTAINING COMPOSITIONS AND METHODS FOR THEIR USE

#1078
US20250090666A1
Human necessities

DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS

#1079 ✅ Patent 12,364,763 granted on 2025-07-22
US20250090667A1
Human necessities

DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS

#1080
US20250090668A1
Human necessities

GLYCOL COMPOSITIONS INCLUDING TOCOPHEROLS

#1081
US20250090669A1
Human necessities

PHARMACEUTICAL SYRUP FORMULATION OR SUSPENSION

#1082
US20250090670A1
Human necessities

DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR

#1083
US20250090671A1
Human necessities

CNP PRODRUGS

#1084
US20250090672A1
Human necessities

CHEMOSELECTIVE THIOL-CONJUGATION WITH ALKENE OR ALKYNE-PHOSPHONAMIDATES

#1085
US20250090673A1
Human necessities

CONJUGATE FOR TARGETING CENTRAL NERVOUS SYSTEM

#1086
US20250090674A1
Human necessities

CARRIER MATERIAL FOR NONTOXIC POLYCATIONIC POLYMER

#1087
US20250090675A1
Human necessities

POLYPEPTIDE CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS

#1088
US20250090676A1
Human necessities

ANTI-FOLATE RECEPTOR ALPHA ANTIBODY CONJUGATES AND THEIR USES

#1089
US20250090677A1
Human necessities

ANTI-CDH6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES THEREOF

#1090
US20250090678A2
Human necessities

B-LYMPHOCYTE SPECIFIC AMATOXIN ANTIBODY CONJUGATES

#1091
US20250090679A1
Human necessities

ANTIBODY-CONJUGATES FOR TARGETING OF TUMOURS EXPRESSING TROP-2

#1092
US20250090680A1
Human necessities

GPC3 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME

#1093
US20250090681A1
Human necessities

NEODEGRADER CONJUGATES

#1094
US20250090682A1
Human necessities

ANTI-MESOTHELIN ANTIBODY AND ANTIBODY DRUG CONJUGATE THEREOF

#1095
US20250090683A1
Human necessities

CONJUGATE TARGETING CARDIOVASCULAR DISEASE

#1096
US20250090684A1
Human necessities

POLYNUCLEOTIDES ENCODING GLUCOSE-6-PHOSPHATASE FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE 1A (GSD1A)

#1097
US20250090685A1
Human necessities

Cationic Hyperbranched Starch-based Gene Carrier, Preparation Method and Application Thereof

#1098
US20250090686A1
Human necessities

Precise Excisions of Portions of Exon 44, 50, and 53 for Treatment of Duchenne Muscular Dystrophy

#1099
US20250090687A1
Human necessities

MITOCHONDRIAL BASE EDITORS AND METHODS FOR EDITING MITOCHONDRIAL DNA

#1100
US20250090688A1
Human necessities

ENGINEERED MUSCLE TARGETING COMPOSITIONS

#1101
US20250090689A1
Human necessities

EXPRESSION CASSETTES FOR TREATING EPILEPSY AND NEUROPATHIC PAIN

#1102
US20250090690A1
Human necessities

METHODS AND SYSTEMS FOR CORRECTING MUTATIONS IN PRPH2

#1103
US20250090691A1
Human necessities

ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR RESTORING PAH GENE FUNCTION AND METHODS OF USE THEREOF

#1104 ✅ Patent 12,357,708 granted on 2025-07-15
US20250090692A1
Human necessities

MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF

#1105
US20250090693A1
Human necessities

BIOCOMPATIBLE COMPOSITION FOR LABELING TARGET LESION, AND PREPARATION METHOD THEREFOR

#1106
US20250090694A1
Human necessities

METHODS AND SYSTEMS FOR PRODUCING, USING, AND ADMINISTERING HYPERPOLARIZED FLUIDS

#1107
US20250090695A1
Human necessities

IMMUNOSTIMULANT-CYTOTOXIC CONJUGATE COMPOSITION AND METHODS FOR CANCER TREATMENT

#1108
US20250090696A1
Human necessities

MACROCYCLIC LIGANDS WITH PENDANT CHELATING MOIETIES AND COMPLEXES THEREOF

#1109
US20250090697A1
Human necessities

ZWITTERIONIC METAL CHELATORS

#1110
US20250090698A1
Human necessities

SMALL MOLECULE INHIBITORS FOR EARLY DIAGNOSIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN CANCERS AND NEURODEGENERATIVE DISEASES

#1111
US20250090699A1
Human necessities

FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF

#1112
US20250090700A1
Human necessities

HUMANIZED ANTIBODY THAT BINDS TO HEG1 PROTEIN AND COMPLEX OF ANTIBODY AND RADIONUCLIDE

#1113
US20250090701A1
Human necessities

APPARATUSES AND METHODS TO ATTENUATE VIRUSES

#1114
US20250090702A1
Human necessities

GASPER KNOB SANITIZATION

#1115
US20250090703A1
Human necessities

LIGHTING DEVICE

#1116
US20250090704A1
Human necessities

MOBILE DEVICE DISINFECTION

#1117
US20250090705A1
Human necessities

STERILIZATION METHOD AND STERILIZATION DEVICE

#1118
US20250090706A1
Human necessities

DISINFECTION ROBOT, SYSTEM FOR DISINFECTION, AND METHOD OF DISINFECTION

#1119
US20250090707A1
Human necessities

ROBOTIC AND AI-AUGMENTED IN SITU DETECTION AND DISINFECTION PLATFORM

#1120
US20250090708A1
Human necessities

Automated Robotic System And Method For Sanitization And Disinfection

#1121
US20250090709A1
Human necessities

SANITATION METHOD AND SYSTEM

#1122
US20250090710A1
Human necessities

Enhanced Dispenser Control

#1123
US20250090711A1
Human necessities

Scent Window Sniffer Card

#1124
US20250090712A1
Human necessities

DIFFUSER

#1125
US20250090713A1
Human necessities

CONTINUOUS DISINFECTION DEVICE

#1126
US20250090714A1
Human necessities

PLASMA AIR PURIFYING APPARATUS

#1127
US20250090715A1
Human necessities

AIR MOVING SANITATION DEVICE

#1128
US20250090716A1
Human necessities

Thimble Bank

#1129
US20250090717A1
Human necessities

THERAPEUTIC USE OF FIBROBLASTS FOR ADHESIVE BANDAGE WOUND HEALING

#1130
US20250090718A1
Human necessities

STABLE COMPOSITIONS COMPOSED OF A RADIOPAQUE AGENT AND CYANOACRYLATE MONOMER AND APPLICATIONS THEREOF

#1131
US20250090719A1
Human necessities

BIOMATERIALS FOR EMBOLIZATION AND DRUG DELIVERY

#1132
US20250090720A1
Human necessities

TUBULAR SCAFFOLD AND METHOD OF MANUFACTURING THE SAME

#1133
US20250090721A1
Human necessities

Charged Citrate-Based Biomaterials

#1134
US20250090722A1
Human necessities

COMPOSITION OF SUBSTANTIALLY SPHERICAL GRANULE FOR BONE REGENERATION

#1135
US20250090723A1
Human necessities

TISSUE GRAFT AND PROCESSING METHODS

#1136
US20250090724A1
Human necessities

SOFT TISSUE PROTEIN COMPOSITIONS, METHODS OF MAKING, AND USES THEREOF

#1137
US20250090725A1
Human necessities

MATERIALS WITH IMPROVED PROPERTIES

#1138
US20250090726A1
Human necessities

METHOD OF TREATING SPINAL DISK

#1139
US20250090727A1
Human necessities

INTEGRATED BIOMATERIAL SCAFFOLD WITH 3D PRINTED LATTICE BACKBONE

#1140
US20250090728A1
Human necessities

SILICONE MATERIAL FUNCTIONALIZED WITH COPPER NANOPARTICLES WHICH REDUCES BACTERIAL LOAD AND BIOFILM FORMATION

#1141
US20250090729A1
Human necessities

Methods and Products to Detect, Minimize and Treat TRAP-Related Tissue Reactions and Tissue Injury Associated With Medical Devices

#1142
US20250090730A1
Human necessities

FLEXICOAT BLOOD-INTERFACE MATERIALS FOR BIO-COMPATABLE IMPLANTS AND DEVICES

#1143
US20250090731A1
Human necessities

BIODEGRADABLE IRON-CONTAINING COMPOSITIONS, METHODS OF PREPARING AND APPLICATIONS THEREFOR

#1144
US20250090732A1
Human necessities

Breast Pumping System

#1145
US20250090733A1
Human necessities

BREAST PUMP DEVICE

#1146
US20250090734A1
Human necessities

OPEN-CLOSED LOOP PERFUSION RESERVOIR

#1147
US20250090735A1
Human necessities

SYSTEM AND METHOD FOR MAINTAINING WORKING PHYSIOLOGICAL RESIN BEAD GEL COMPOSITION WITHIN AN ARTIFICIAL KIDNEY

#1148
US20250090736A1
Human necessities

Transfer Set with Integral Access Port

#1149
US20250090737A1
Human necessities

APPROACHES TO MITIGATING PRESSURE APPLIED TO IMMOBILIZED PATIENTS UNDERGOING TREATMENT BY UNDERLYING SURFACES AND ASSOCIATED SYSTEMS

#1150
US20250090738A1
Human necessities

APPROACHES TO MITIGATING PRESSURE APPLIED TO IMMOBILIZED PATIENTS UNDERGOING TREATMENT BY UNDERLYING SURFACES AND ASSOCIATED SYSTEMS

#1151
US20250090739A1
Human necessities

PRESSURE-MITIGATION APPARATUSES FOR IMPROVED TREATMENT OF IMMOBILIZED PATIENTS AND ASSOCIATED SYSTEMS AND METHODS

#1152
US20250090740A1
Human necessities

Portable Device With Disposable Reservoir For Collection Of Internal Fluid After Surgery From A Plurality Of Sites Simultaneously

#1153
US20250090741A1
Human necessities

SYSTEMS AND METHODS FOR DETECTING NEGATIVE PRESSURE WOUND THERAPY DRESSING LEAKAGE USING STETHOSCOPE

#1154
US20250090742A1
Human necessities

ENDOLUMINAL TREATMENT DEVICES AND RELATED METHODS

#1155
US20250090743A1
Human necessities

CANISTER CONNECTION SYSTEM FOR DISPOSABLE NEGATIVE PRESSURE WOUND THERAPY SYSTEM

#1156
US20250090744A1
Human necessities

ENERGY DELIVERY DEVICE AND METHODS OF USE

#1157
US20250090745A1
Human necessities

DRUG SOLUTION INJECTION DEVICE

#1158
US20250090746A1
Human necessities

Smart Wearable Injection and/or Infusion Device

#1159
US20250090747A1
Human necessities

Apparatus of Cerebrospinal Fluid Pump

#1160
US20250090748A1
Human necessities

FLUID DELIVERY SYSTEMS AND METHODS FOR CONTINUOUS FLUID FLOW

#1161
US20250090749A1
Human necessities

MEDICAL FLUID CONTROL DEVICE

#1162
US20250090750A1
Human necessities

SYSTEMS, APPARATUSES AND METHODS FOR OCCLUSION DETECTION USING PUMP OPERATION MEASUREMENT

#1163
US20250090751A1
Human necessities

ELECTRONIC DEVICE FOR COLLECTING DRUG INJECTION INFORMATION ACCORDING TO USE OF PATIENT-CONTROLLED ANALGESIA (PCA) DEVICE, CONTROL METHOD THEREFOR, AND SYSTEM

#1164
US20250090752A1
Human necessities

CLOSED LOOP INFUSION PUMP CONTROL

#1165
US20250090753A1
Human necessities

TREND BASED ADJUSTMENTS TO INSULIN DOSAGE

#1166
US20250090754A1
Human necessities

METHOD TO AVOID HYPOGLYCEMIA BY MINIMIZING LATE POST-PRANDIAL INSULIN INFUSION IN AID SYSTEM

#1167
US20250090755A1
Human necessities

DOSING OF INCRETIN PATHWAY DRUGS

#1168
US20250090756A1
Human necessities

Switching Between Medicament Delivery Control Algorithms

#1169
US20250090757A1
Human necessities

CARTRIDGE ASSEMBLY AND METHOD FOR ASSEMBLING THE SAME

#1170
US20250090758A1
Human necessities

A BOTULINUM TOXIN SYRINGE

#1171
US20250090759A1
Human necessities

Gliding Performances Improved Through Trim Rib Dimensional Geometry/Shape

#1172
US20250090760A1
Human necessities

END OF DOSE INDICATORS

#1173
US20250090761A1
Human necessities

EXCESS DOSE ALERT SYSTEM FOR A DOSING PEN

#1174
US20250090762A1
Human necessities

ELECTRONIC ENCODER MODULE FOR A DRUG DELIVERY DEVICE AND DRUG DELIVERY DEVICE

#1175
US20250090763A1
Human necessities

PRECISION SYRINGE ACTUATOR SYSTEM

#1176
US20250090764A1
Human necessities

DETACHABLE NEEDLE PROTECTION CAP FOR INJECTION DEVICES

#1177
US20250090765A1
Human necessities

AUTOINJECTOR WITH ANTI-ACTIVATION FEATURE

#1178
US20250090766A1
Human necessities

SAFETY DEVICE FOR A NEEDLE AND SAFETY NEEDLE SYSTEM COMPRISING A SAFETY DEVICE

#1179
US20250090767A1
Human necessities

Safety Device for a Syringe

#1180
US20250090768A1
Human necessities

PUNCTURE DEVICE AND MEDICINAL SOLUTION ADMINISTERING DEVICE EQUIPPED WITH PUNCTURE DEVICE

#1181
US20250090769A1
Human necessities

CLAMPING DEVICE FOR STEADY NEEDLE INJECTING

#1182
US20250090770A1
Human necessities

NOZZLE

#1183
US20250090771A1
Human necessities

ELECTRONIC DEVICES AND LIQUIDS FOR AEROSOLIZING AND INHALING THEREWITH

#1184
US20250090772A1
Human necessities

A METHOD AND AN INSUFFLATOR FOR DETERMINING A VALUE OF A VOLUME OF INSUFFLATING GAS TO BE DRAWN FROM AN INSUFFLATED CAVITY DURING EVACUATING OF THE CAVITY

#1185
US20250090773A1
Human necessities

REPLACEABLE FLOW TRACT FOR AN INHALER

#1186
US20250090774A1
Human necessities

DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY

#1187
US20250090775A1
Human necessities

AEROSOL-GENERATING SYSTEM WITH FLUID SENSOR

#1188
US20250090776A1
Human necessities

COMPACT INHALER MECHANISM

#1189
US20250090777A1
Human necessities

TREATMENT OF PULMONARY CANCERS USING AN ELECTRONIC BREATH ACTUATED DROPLET DELIVERY DEVICE

#1190
US20250090778A1
Human necessities

Nasal Administration

#1191
US20250090779A1
Human necessities

ASSEMBLY FOR CONTROLLING THE NASAL DELIVERY OF A PRODUCT, AND ASSOCIATED DELIVERY SYSTEM AND CONTROL METHOD

#1192
US20250090780A1
Human necessities

ENDOTRACHEAL TUBE WITH PRESSURE SENSOR AND A METHOD OF MANUFACTURE THEREOF

#1193
US20250090781A1
Human necessities

DIFFERENTIAL PRESSURE FLOW METER

#1194
US20250090782A1
Human necessities

Nasal Cannula Assembly

#1195
US20250090783A1
Human necessities

Electronic Nasal Cannula Flame Detector And Oxygen Shutoff Device

#1196
US20250090784A1
Human necessities

MAGNETIC CONNECTOR

#1197
US20250090785A1
Human necessities

CONNECTORS FOR RESPIRATORY ASSISTANCE SYSTEMS

#1198
US20250090786A1
Human necessities

SYSTEMS AND METHODS FOR GENERATING CONCENTRATED OXYGEN

#1199
US20250090787A1
Human necessities

BREATHING TUBE WITH A MORE EASILY INTERCHANGEABLE BREATHING-GAS FILTER

#1200
US20250090788A1
Human necessities

HUMIDIFIER RESERVOIR